Revolution Medicines is seeking a Director of HEOR/RWE for lung cancer to lead evidence generation initiatives that demonstrate the value of its oncology treatments. The role requires extensive experience in health economics and outcomes research, particularly within the oncology sector, and offers a competitive salary range.
Base: $211,000 - $264,000 USD; Bonus/Equity: Competitive cash compensation and robust equity awards; Benefits: Strong benefits and significant learning opportunities
Must-have
Nice-to-have
Not specified